ARNA news: Arena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary Arena Pharmaceuticals (ARNA) announced that its wholly owned subsidiary, Arena Pharmaceuticals, has entered into an exclusive marketing and supply agreement for BELVIQ with Teva Pharmaceutical Industries Limited's (TEVA) local Israeli subsidiary, Abic Marketing Limited. Under the agreement, Arena granted Abic the rights to market and distribute BELVIQ in Israel for weight loss or weight management in obese and overweight patients, subject to regulatory approval by the State of Israel Ministry of Health.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.